Indonesia Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

  • Published : Aug 2022
  • Report Code : KSI061613420
  • Pages : 90

Indonesia’s infection control market is evaluated at US$84.046 million for the year 2020 and is projected to grow at a CAGR of 8.74% to reach a market size of US$151.091 million by the year 2027.

Federal agencies such as the Centers for Disease Control and Prevention (CDC) are making extreme and reasonable efforts in Indonesia in order to accelerate the improvement of the country’s ability to effectively and timely detect, prevent, and respond to the outbreaks of infectious diseases so that they do not turn into epidemics. In addition, CDC is also engaged in working with the Ministry of Health (MOH) and providing their expertise to aid in the development of core public health facilities in disease and infection surveillance and emergency engagement, among some other areas. Moreover, the programs such as PASIMAS (Penyediaan Air Minum dan Sanitasi Berbasis Masyarakat or Community Based Drinking Water Supply and Sanitation) are increasingly involved and aimed toward the provision of clean and safe drinking water to the low-income and rural population in Indonesia, minimizing the risk of severe infections and hospitalizations.

In addition, Indonesia is a participating country in the Global Health Security Agenda (GHSA), which was set in order to ensure that safer practices are being followed by medical institutions and other healthcare establishments in order to ensure that the infection can be controlled and prevented effectively. Some of the measures under this agenda include action packages for antimicrobial resistance and biosafety and biosecurity. As antimicrobial resistance occurs when the medications used to cure and control the infections are rendered infective due to the changing microorganisms such as bacteria, viruses, and parasites, among others, it is essential to have effective antimicrobials to prevent and control the infections, to minimize the spread of diseases. This action plan aims to combat antimicrobial resistance by addressing human and animal health, food production, and other aspects by following proper infection control procedures and engagement and collaboration from multiple sectors. The biosafety and biosecurity action plan deals with the timely prevention and control of biological events that can endanger public health if adequate preparedness is missing. In order to deal with this, the infrastructure and resources must be advanced, with standard hygiene and disinfection techniques being followed.

Sterilization to increase its share over the next few years

Sterilization is projected to hold a significant share over the forecast period and increase its share over the next few years since there has been active participation of the Centers for Disease Control and Prevention and the implementation of action plans such as the Global Health and Safety Agenda. This is to make the healthcare provider and caretakers aware of the risks of not following proper hand hygiene, environmental hygiene, infection control precautions, and continuous disinfection so that outbreaks of infections and diseases can be controlled timely and efficiently. In addition, one of the major players, Tuttnauer, which has a global presence, is involved in the provision of sterilization equipment such as washer-disinfectors, autoclaves, and plasma disinfectors for laboratories, medical centres, dental clinics, and veterinary clinics. Thus, this factor will contribute to the increased adoption and aid in increasing the market share of sterilization equipment.

COVID-19 SCENARIO

Infection control sales in Indonesia were mostly fueled by the recent coronavirus pandemic outbreak. The outbreak increased the need for surface cleaners in the nation. Additionally, since there are more COVID-19 cases have been confirmed, there is a greater need for testing and quarantine facilities, which will eventually increase the demand for infection control products in the forecast period. Since 2020, Reckitt has introduced a number of new products, such as the Dettol Disinfectant Spray, Dettol Antiseptic Liquid huge 1L container, and the reasonably priced nourishment Enfa Essential. With its selection of household hygiene products that have been proven effective against the Covid-19 Virus, Reckitt continues to help Indonesia stay protected.

Indonesia Infection Control Market Scope:

 

Report Metric Details
 Market Size Value in 2020  US$84.046 million
 Market Size Value in 2027  US$151.091 million
 Growth Rate  CAGR of 8.74% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Million
 Segments Covered  Product, And End-User Industry
 Companies Covered  Drägerwerk AG & Co. KGaA, 3M, B. Braun Melsungen AG, Tuttnauer,  BD
 Customization Scope  Free report customization with purchase

 

Market Segmentation

  • By Product
    • Disinfectant
    • Sterilization
      • Low-Temperature Sterilization
      • Heat Sterilization
      • Contract Sterilization
  • By End-User Industry
    • Healthcare
    • Food and Beverage
    • Chemical

1. Introduction
1.1.  Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2.  Research Methodology
2.1.  Research Data
2.2.  Assumptions

3.  Executive Summary
3.1.  Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4.  Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Indonesia Infection Control Market by Product
5.1.  Introduction
5.2. Disinfectant
5.3. Sterilization 
5.3.1.  Low-Temperature Sterilization
5.3.2.  Heat Sterilization
5.3.3. Contact Sterilization

6. Indonesia Infection Control Market by End-User Industry
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical

7. Competitive Environment and Analysis
7.1. Major Players and Strategy Analysis
7.2.  Emerging Players and Market Lucrativeness
7.3.  Mergers, Acquisitions, Agreements, and Collaborations
7.4.  Vendor Competitiveness Matrix

8. Companies Profiles
8.1. Drägerwerk AG & Co. KGaA
8.2. 3M
8.3. B. Braun Melsungen AG
8.4. Tuttnauer
8.5.  BD

Drägerwerk AG & Co. KGaA

 3M

 B. Braun Melsungen AG

 Tuttnauer

 BD